Similar drugsTo uncover
Dosage form: & nbsptabscesses
Composition:Ha 1 tablet:

Active substances:

Sodium dihydrogen phosphate monohydrate 1102.0 mg

Sodium hydrogen phosphate 398.0 mg

Excipients:

Macrogol 8000 167.6 mg

Magnesium stearate 8.4 mg

Description:

Oval biconvex tablets from white to almost white, on the one hand - delicate risk, engraving "SLX" on one half and "102" on the other, on the other side of the tablet without risks and inscriptions.

Pharmacotherapeutic group:Laxative
ATX: & nbsp
  • Laxative preparations with osmotic properties
  • Pharmacodynamics:

    Has a hyperosmotic laxative effect due to increased osmotic pressure in the lumen of the small intestine. The accumulation of fluid in the ileum causes stretching of the intestine, as a result of which the peristalsis is intensified and the bowel movement is accelerated.

    Indications:

    Cleansing of the colon with a view to preparing for colonoscopy, surgical operations requiring the absence of contents in the large intestine, radiographic examination of the abdominal cavity organs.

    Contraindications:

    - Children under 18 years;

    - elderly age over 75;

    - hypersensitivity to the components of the drug;

    - pregnancy and the period of breastfeeding.

    Do not use in patients with the following medical history:

    - clinically significant kidney failure;

    - primary hyperparathyroidism associated with hypercalcemia;

    - congestive heart failure;

    - unstable angina;

    - ascites;

    - established or suspected obstruction, severe chronic constipation;

    - megacolon (congenital or acquired), or patients who underwent an operation to bypass the stomach;

    - syndrome of hypokinesia (as a result of hypothyroidism, scleroderma);

    - perforation of the intestine;

    - active inflammatory bowel disease.

    Carefully:

    - Patients with a high risk of renal failure, having previous electrolyte disorders or the risk of electrolyte disorders;

    - patients with clinically significant arterial hypotension (also associated with hypovolemia);

    - patients with heart disease, acute myocardial infarction, unstable angina; patients of advanced age or weakened patients. This group of risk should be monitored before and after the application of sodium, potassium, chloride, bicarbonate, phosphate, urea and creatinine in the blood serum;

    - patients with gastrointestinal hypokinesia; after surgical intervention in the gastrointestinal tract in the anamnesis; with other diseases predisposing to gastrointestinal hypokinesia; in patients on a diet low in salt.

    - patients taking medications that inhibit angiotensin-converting enzyme;

    - Patients taking medications that block angiotensin receptors or diuretics;

    - patients taking non-steroidal anti-inflammatory drugs - with the simultaneous administration of laxatives, dehydration and hypovolemia can be intensified;

    - Patients taking parathyroid hormone (parathyroid hormone regulates serum calcium levels by affecting the bones, kidneys and intestines, and also reduces the reabsorption of phosphates from the proximal tubule of the kidneys, and this increases the release of phosphate in the urine, as the drug "Kolokit "contains phosphates, there is a risk of interaction).

    One tablet of the drug COLOKIT contains 313 mg sodium, take this into account if you follow a diet with a lower sodium content.

    Pregnancy and lactation:

    Do not use during pregnancy and lactation.

    Dosing and Administration:

    Start the reception of the drug KOLOKIT follows the day before the examination (operation). The day before the examination (surgery), the patient can have breakfast with low-fiber foods (coffee or tea with sugar or without, toast, butter or fruit jelly or honey). During lunch and later only allowed to drink. You can drink water, light soup, diluted fruit juice without pulp, not strong tea or black coffee, fizzy drinks.

    The drug COLOKIT should be taken as follows:

    The day before the examination (operation):

    1. Take 4 tablets with 250 ml of water (or other liquid),

    Then repeat 4 times (4 tablets with 250 ml of water or other liquid) with an interval of 15 minutes. Thus, in total 20 tablets should be taken.

    On the day of the examination (4-5 hours before the examination / operation):

    1. Take 4 tablets with 250 ml of water or another liquid,

    2. Then repeat 2 times (4 tablets with 250 ml of water or another liquid) at an interval of 15 minutes, so that a total of 12 tablets.

    Side effects:

    Adverse reactions of the drug are systematized relative to each of the organ systems depending on the frequency of occurrence, using the following classification:

    Very often (≥ 1/10);

    Often (≥ 1/100, <1/10);

    Infrequently (≥ 1/1000, <1/100);

    Rarely (≥ 1/10000, <1/1000);

    Very rarely (<1/10000), including isolated cases.

    Immune system disorders:

    Rarely, allergic dermatitis or hypersensitivity reaction.

    Disturbances from the nervous system:

    Often - headache, dizziness;

    Very rarely - paresthesia, generalized tonic-clonic seizures.

    Metabolic disorders:

    Rarely - dehydration;

    Very rarely - hyperphosphataemia, hypocalcemia, hypokalemia, hypernatremia, metabolic acidosis.

    Disorders from the cardiovascular system:

    Very rarely - myocardial infarction, arrhythmia, hypotension.

    Disorders from the gastrointestinal tract:

    Very often - diarrhea, abdominal pain, bloating, nausea;

    Often - vomiting, abnormal colonoscopy (single or multiple aphthous ulcers localized in sigmoid colon or rectum, not clinically significant and spontaneously disappearing without therapy), abnormal gastroscopy (erythematous gastritis with lesions and / or necrotic superficial ulceration in the intestine, most often which are asymptomatic and spontaneously regressive)

    General disorders and complications at the site of drug administration:

    Very rarely: chills, asthenia.

    Disturbances from the musculoskeletal and connective tissue:

    Very rarely - muscle cramps.

    Disorders from the kidneys and urinary tract:

    Increase in the content of nitrogen in the urine, an increase in creatinine, acute renal failure, nephrocalcinosis, acute phosphate nephropathy, and acute tubular necrosis.

    Overdose:

    Overdose Symptoms: dehydration, hypotension, tachycardia, bradycardia, tachypnea, cardiac arrest, shock, respiratory arrest, dyspnea, convulsions, paralytic ileus, anxiety, pain.

    Overdose can lead to an increase in the concentration of sodium and phosphate in the blood serum and decrease the concentration of calcium and potassium. In this case, hypernatremia, hyperphosphatemia, hypocalcemia, hypokalemia and acidosis may develop.

    Overdose therapy: rehydration and intravenous calcium gluconate 10%.

    Interaction:

    With simultaneous administration with drugs - calcium channel blockers, diuretics, lithium preparations or other drugs that can affect the concentration of electrolytes in the blood serum,the probability of hyperphosphataemia, hypocalcaemia, hypokalemia, hypernatremic dehydration or acidosis increases.

    With the simultaneous use of the drug COLOKIT, the effectiveness of oral contraceptives, antiepileptic drugs, antidiabetics can be partially reduced or completely absent.

    Special instructions:

    It is necessary to explain to the patient the importance of strict adherence to the regimen of taking the drug and using as much liquid as possible to avoid dehydration. The use of large amounts of water also contributes to maximum cleansing of the colon.

    The drug COLOKIT can be taken again not earlier than 7 days after the previous reception.

    The drug KOLOKIT can not be taken simultaneously with other laxatives (especially with drugs containing sodium phosphate).

    The drug COLOKIT should not be used to treat constipation.

    The drug COLOKIT usually operates for 0.5 hours to 6 hours after admission. In case the intestinal motility did not increase during 6 hours after taking the drug, you should stop taking the drug KOLOKIT and immediately consult a doctor,as there is a risk of dehydration.

    One tablet contains 313 mg of sodium: consider this if you follow a diet with a low sodium content.

    Effect on the ability to drive transp. cf. and fur:

    The drug may cause drowsiness, possibly associated with dehydration. Therefore, it is prohibited to drive vehicles and control mechanisms during the period of application of the drug.

    Form release / dosage:Pills.
    Packaging:

    For 32 tablets in a bottle of high-density polyethylene with a propylene lid with a mechanism for protection from opening by children, containing two packages with a desiccant silica gel.

    1 a bottle with instructions for medical use in a cardboard box.

    Storage conditions:

    At a temperature not higher than 25 ° C, out of the reach of children.

    Shelf life:

    3 years.

    Do not use after the expiry date printed on the package.

    Terms of leave from pharmacies:On prescription
    Registration number:LP-003659
    Date of registration:31.05.2016 / 06.12.2017
    Expiration Date:31.05.2021
    The owner of the registration certificate:Laboratories MAYOLI-SPINDLERLaboratories MAYOLI-SPINDLER France
    Manufacturer: & nbsp
    Representation: & nbspMAYOLI SPINDLER, LLCMAYOLI SPINDLER, LLCRussia
    Information update date: & nbsp31.01.2018
    Illustrated instructions
    Instructions
    Up